ArticleTherapeutic advances in medical oncology2019

Pemetrexed/carboplatin plus gefitinib as a first-line treatment for EGFR-mutant advanced nonsmall cell lung cancer: a Bayesian network meta-analysis.

Zhonghan Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.